神経バイオマーカー市場は2023年から2028年に78億2,000万米ドル、予測期間中のCAGRは13.01%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。神経疾患の罹患率の上昇、神経疾患特異的バイオマーカーの臨床試験の増加、神経ヘルスケアへのアクセスを改善するための政府による取り組みや支援の増加が市場を牽引しています。
本調査では、今後数年間の神経バイオマーカー市場成長を牽引する主な要因の一つとして、正確な神経学的診断への注目の高まりを挙げています。また、血液ベースのバイオマーカーの利用可能性の高まりとマニュアルmiRNAの進化は、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global neurological biomarkers market 2018 - 2022
4.2 End-user Segment Analysis 2018 - 2022
4.3 Indication Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by End-user
6.1 Market segments
6.2 Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
6.4 Clinical diagnostic centers - Market size and forecast 2023-2028
6.5 Research organizations and others - Market size and forecast 2023-2028
6.6 Market opportunity by End-user
7 Market Segmentation by Indication
7.1 Market segments
7.2 Comparison by Indication
7.3 AD - Market size and forecast 2023-2028
7.4 PD - Market size and forecast 2023-2028
7.5 ASD - Market size and forecast 2023-2028
7.6 MS - Market size and forecast 2023-2028
7.7 Others - Market size and forecast 2023-2028
7.8 Market opportunity by Indication
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 UK - Market size and forecast 2023-2028
9.10 China - Market size and forecast 2023-2028
9.11 France - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Abbott Laboratories
12.4 ACROBIOSYSTEMS INC.
12.5 Alseres Pharmaceuticals Inc
12.6 Bio Rad Laboratories Inc.
12.7 bioMerieux SA
12.8 Eli Lilly and Co.
12.9 F. Hoffmann La Roche Ltd.
12.10 IQVIA Holdings Inc.
12.11 Merck KGaA
12.12 Metabolon Inc.
12.13 PerkinElmer Inc
12.14 Proteome Sciences plc
12.15 QIAGEN NV
12.16 Quanterix Corp.
12.17 Thermo Fisher Scientific Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global neurological biomarkers market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Research organizations and others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Research organizations and others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Indication - Market share 2023-2028 (%)
Exhibits49: Data Table on Indication - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Indication
Exhibits51: Data Table on Comparison by Indication
Exhibits52: Chart on AD - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on AD - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on AD - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on AD - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on PD - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on PD - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on PD - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on PD - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on ASD - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on ASD - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on ASD - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on ASD - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on MS - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on MS - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Indication ($ billion)
Exhibits73: Data Table on Market opportunity by Indication ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key news
Exhibits126: Abbott Laboratories - Key offerings
Exhibits127: Abbott Laboratories - Segment focus
Exhibits128: ACROBIOSYSTEMS INC. - Overview
Exhibits129: ACROBIOSYSTEMS INC. - Product / Service
Exhibits130: ACROBIOSYSTEMS INC. - Key offerings
Exhibits131: Alseres Pharmaceuticals Inc - Overview
Exhibits132: Alseres Pharmaceuticals Inc - Product / Service
Exhibits133: Alseres Pharmaceuticals Inc - Key offerings
Exhibits134: Bio Rad Laboratories Inc. - Overview
Exhibits135: Bio Rad Laboratories Inc. - Business segments
Exhibits136: Bio Rad Laboratories Inc. - Key news
Exhibits137: Bio Rad Laboratories Inc. - Key offerings
Exhibits138: Bio Rad Laboratories Inc. - Segment focus
Exhibits139: bioMerieux SA - Overview
Exhibits140: bioMerieux SA - Product / Service
Exhibits141: bioMerieux SA - Key news
Exhibits142: bioMerieux SA - Key offerings
Exhibits143: Eli Lilly and Co. - Overview
Exhibits144: Eli Lilly and Co. - Product / Service
Exhibits145: Eli Lilly and Co. - Key news
Exhibits146: Eli Lilly and Co. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Overview
Exhibits148: F. Hoffmann La Roche Ltd. - Business segments
Exhibits149: F. Hoffmann La Roche Ltd. - Key news
Exhibits150: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits152: IQVIA Holdings Inc. - Overview
Exhibits153: IQVIA Holdings Inc. - Business segments
Exhibits154: IQVIA Holdings Inc. - Key news
Exhibits155: IQVIA Holdings Inc. - Key offerings
Exhibits156: IQVIA Holdings Inc. - Segment focus
Exhibits157: Merck KGaA - Overview
Exhibits158: Merck KGaA - Business segments
Exhibits159: Merck KGaA - Key news
Exhibits160: Merck KGaA - Key offerings
Exhibits161: Merck KGaA - Segment focus
Exhibits162: Metabolon Inc. - Overview
Exhibits163: Metabolon Inc. - Product / Service
Exhibits164: Metabolon Inc. - Key offerings
Exhibits165: PerkinElmer Inc - Overview
Exhibits166: PerkinElmer Inc - Business segments
Exhibits167: PerkinElmer Inc - Key news
Exhibits168: PerkinElmer Inc - Key offerings
Exhibits169: PerkinElmer Inc - Segment focus
Exhibits170: Proteome Sciences plc - Overview
Exhibits171: Proteome Sciences plc - Product / Service
Exhibits172: Proteome Sciences plc - Key offerings
Exhibits173: QIAGEN NV - Overview
Exhibits174: QIAGEN NV - Product / Service
Exhibits175: QIAGEN NV - Key news
Exhibits176: QIAGEN NV - Key offerings
Exhibits177: Quanterix Corp. - Overview
Exhibits178: Quanterix Corp. - Product / Service
Exhibits179: Quanterix Corp. - Key offerings
Exhibits180: Thermo Fisher Scientific Inc. - Overview
Exhibits181: Thermo Fisher Scientific Inc. - Business segments
Exhibits182: Thermo Fisher Scientific Inc. - Key news
Exhibits183: Thermo Fisher Scientific Inc. - Key offerings
Exhibits184: Thermo Fisher Scientific Inc. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations
